dr. cobleigh on antibody-drug conjugates in development in her2 breast cancer
Published 5 years ago • 156 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:38
dr. hart on antibody-drug conjugates in her2 breast cancer
-
3:36
her2 breast cancer: evolution of antibody-drug conjugates
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
18:25
emerging antibody-drug conjugates in breast cancer: an expert analysis of promising therapies
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
14:08
her2 amplification and breast cancer part 1
-
10:11
a brief introduction of antibody drug conjugate - creative biolabs
-
3:09
breast cancer and the estrogen connection: plastics
-
0:49
optimizing patient selection for antibody drug conjugates in breast cancer
-
6:44
antibody-drug conjugates in treating tnbc
-
2:11
next-generation antibody-drug conjugates in her2 breast cancer
-
5:59
use of antibody drug conjugates and potential for ild
-
3:42
antibody drug conjugates in metastatic breast cancer | anthony elias, md | esmo22 colorado
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
1:32
antibody-drug conjugates in urothelial carcinoma
-
2:10
targeting low her2 expression with antibody-drug conjugates
-
18:35
managing adverse events of novel antibody-drug conjugates in breast cancer